JPI-289

DRUG2 trials

Sponsors

Jeil Pharmaceutical Co., Ltd.

Conditions

Stroke

Phase 1

The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers

CompletedNCT01983358

Jeil Pharmaceutical Co., Ltd.Stroke

Start: 2013-11-30End: 2014-09-30Updated: 2016-06-24

The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

CompletedNCT02396069

Jeil Pharmaceutical Co., Ltd.Stroke

Start: 2015-03-31End: 2015-08-31Updated: 2016-06-24